Product Information
NAFTIFINE HCL 1% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $4.1929 per GM under NDC 51672136203. Its NADAC has been published 160 times since Jan 18, 2017.
FDA first approved this application on Sep 8, 2016.
Strength
10 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672136203
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NAFTIFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205975FDA Approved
9/8/2016
On Market Since
9/8/2016
Pharmacological Classes
Price Statistics
The NADAC for NAFTIFINE HCL 1% CREAM has been published 160 times since Jan 18, 2017, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1929 per GM |
|---|---|
| All-time high | $5.0179 (Aug 16, 2017) |
| All-time low | $4.1929 (Sep 23, 2026) |
| 52-week high | $4.7622 |
| 52-week low | $4.1929 |
| Median price | $4.6248 |
| Average price | $4.6619 |
| Largest weekly change | -9.0% (Apr 17, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jan 18, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naftifine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naftifine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Allylamine Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAFTIFINE HCL 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NAFTIFINE HCL 1% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $4.1929 per GM (NDC 51672136203), effective Sep 30, 2026.
How has the price of NAFTIFINE HCL 1% CREAM changed over time?
Over the history we have for it, the NADAC for NAFTIFINE HCL 1% CREAM has declined 16.4%. It has been tracked across 160 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for NAFTIFINE HCL 1% CREAM?
Since Jan 18, 2017, the NADAC for NAFTIFINE HCL 1% CREAM has ranged from a low of $4.1929 (Sep 23, 2026) to a high of $5.0179 (Aug 16, 2017), with a median of $4.6248 per GM.
Are there cheaper alternatives to NAFTIFINE HCL 1% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of NAFTIFINE HCL 1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAFTIFINE HCL 1% CREAM?
NAFTIFINE HCL 1% CREAM (NDC 51672136203) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.